Lee Smith

home / authors / lee-smith

Lee Smith, RNFA, BSN, MBA, is vice president of Clinical Solutions at Syft, a healthcare supply chain management company. Smith has more than 35 years of experience in healthcare, including numerous years in hospitals as well as 20 years in supply chain and information technology.

Articles

Hospitals Aren’t Investing Enough in the Supply Chain and They’re Paying the Price

Hospitals Aren’t Investing Enough in the Supply Chain and They’re Paying the Price

Betty Jo Rocchio;Lee Smith
February 21st 2022

A look at the challenges hospitals face due to an insufficient supply chain—and how to address them.

Read More

Why Building a Nurse-Centric Supply Chain Matters

Why Building a Nurse-Centric Supply Chain Matters

Lee Smith
August 20th 2021

Eighty-six percent of nurses said supply chain workflows cause them stress and 85% said documenting supplies is challenging.

Read More

Latest Updated Articles

Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
black and white image of solders in jungle setting | ©daniel stock.adobe.com
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
food in heart shape with a stethoscope | image credit: ©udra11
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
The future of diabetes management: expanding access to and impact of CGM for patients with type 2 diabetes
Published: July 16th 2025 | Updated: July 30th 2025
The future of diabetes management: expanding access to and impact of CGM for patients with type 2 diabetes
For GLP-1s and Biosimilars, Some Celebration, Some Concern, Survey Finds | MHE 2025 Pharmacy Survey, Part 3
Published: May 20th 2025 | Updated: July 30th 2025
For GLP-1s and Biosimilars, Some Celebration, Some Concern, Survey Finds | MHE 2025 Pharmacy Survey, Part 3
© 2025 MJH Life Sciences

All rights reserved.